Department for Developmental and Molecular Genetics, VIB, Leuven, Belgium.
EMBO Mol Med. 2011 May;3(5):291-302. doi: 10.1002/emmm.201100138. Epub 2011 Apr 15.
BACE1 cleaves the amyloid precursor protein (APP) at the β-cleavage site (Met(671) -Asp(672) ) to initiate the generation of amyloid peptide Aβ. BACE1 is also known to cleave APP at a much less well-characterized β'-cleavage site (Tyr(681) -Glu(682) ). We describe here the identification of a novel APP mutation E682K located at this β'-site in an early onset Alzheimer's disease (AD) case. Functional analysis revealed that this E682K mutation blocked the β'-site and shifted cleavage of APP to the β-site, causing increased Aβ production. This work demonstrates the functional importance of APP processing at the β'-site and shows how disruption of the balance between β- and β'-site cleavage may enhance the amyloidogenic processing and consequentially risk for AD. Increasing exon- and exome-based sequencing efforts will identify many more putative pathogenic mutations without conclusive segregation-based evidence in a single family. Our study shows how functional analysis of such mutations allows to determine the potential pathogenic nature of these mutations. We propose to classify the E682K mutation as probable pathogenic awaiting further independent confirmation of its association with AD in other patients.
BACE1 在β 裂解位点(Met(671)-Asp(672))切割淀粉样前体蛋白 (APP),从而启动淀粉样肽 Aβ 的产生。BACE1 也已知在一个不太明确的 β'-裂解位点(Tyr(681)-Glu(682))切割 APP。我们在这里描述了一种位于早发性阿尔茨海默病 (AD) 病例中该 β'-位点的新型 APP 突变 E682K 的鉴定。功能分析表明,该 E682K 突变阻断了 β'-位点,并将 APP 的切割转移到 β-位点,导致 Aβ 产量增加。这项工作证明了 APP 在 β'-位点加工的功能重要性,并表明β-和 β'-位点切割之间平衡的破坏如何增强淀粉样蛋白加工和 AD 的风险。增加基于外显子和外显子组的测序工作将在单个家族中没有基于结论性分离的明确证据的情况下识别出更多可能的致病性突变。我们的研究表明,如何对这些突变进行功能分析可以确定这些突变的潜在致病性。我们建议将 E682K 突变分类为可能的致病性,等待在其他患者中进一步独立确认其与 AD 的关联。